drugset / Trial / NCT06281236
A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR)
NaSingle-groupOpen-labelTreatment
Summary
This will be an open label phase 1b trial to characterize the pharmacodynamics and PK of prednisolone and SPI-62 when co-administered to participants with PMR. Up to 24 participants could be recruited.
Timeline
- Start
- 2022-02-22
- Primary completion
- 2025-03-25
- Completion
- 2025-04-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prednisolone | Other / unclassified | — | — |
| Subject | clofutriben | Small molecule | — | — |